{"@context": "https://schema.org", "@type": "BreadcrumbList", "itemListElement": [{"@type": "ListItem", "position": 1, "name": "Home", "item": "https://www.patentleaderboard.com/"}, {"@type": "ListItem", "position": 2, "name": "2021", "item": "https://www.patentleaderboard.com/2021/"}, {"@type": "ListItem", "position": 3, "name": "Macrogenics", "item": "https://www.patentleaderboard.com/2021/company/macrogenics"}, {"@type": "ListItem", "position": 4, "name": "Scott Koenig", "item": "https://www.patentleaderboard.com/2021/inventor/fl:sc_ln:koenig-1"}]}
Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
SK

Scott Koenig — 5 Patents in 2021

MAMacrogenics: 5 patents #3 of 18Top 20%
Rockville, MD: #9 of 275 inventorsTop 4%
Maryland: #89 of 3,967 inventorsTop 3%
Overall (2021): #27,983 of 548,734Top 6%
5 Patents 2021

Issued Patents 2021

Showing 1–5 of 5 patents

Patent #TitleCo-InventorsDateApprox Value ⓘ
11174315 Combination therapy for the treatment of cancer James Vasselli, Jon M. Wigginton, Ezio Bonvini 2021-11-16 $17,746,000
11098119 Covalently bonded diabodies having immunoreactivity with PD-1 and LAG-3, and methods of use thereof Ezio Bonvini, Leslie S. Johnson, Kalpana Shah, Ross La Motte-Mohs, Paul A. Moore 2021-08-24 $9,808,000
11078279 Combination therapy for the treatment of cancer Jon M. Wigginton, Naimish Bharat Pandya, Robert Joseph Lechleider, Ezio Bonvini 2021-08-03 $21,594,000
11072653 LAG-3-binding molecules and methods of use thereof Ross La Motte-Mohs, Kalpana Shah, Douglas H. Smith, Leslie S. Johnson, Paul A. Moore +1 more 2021-07-27 $22,267,000
10954301 Bispecific molecules having immunoreactivity with PD-1 and CTLA-4, and methods of use thereof Leslie S. Johnson, Gurunadh Reddy Chichili, Kalpana Shah, Ross La Motte-Mohs, Paul A. Moore +1 more 2021-03-23 $115,266,000